Abstract:
Studies of oral corticosteroid dose and loss of bone mineral density have reported inconsistent results. In this meta-analysis, we used information from 66 papers on bone density and 23 papers on fractures to examine the effects of oral corticosteroids on bone mineral density and risk of fracture. Strong correlations were found between cumulative dose and loss of bone mineral density and between daily dose and risk of fracture. The risk of fracture was found to increase rapidly after the start of oral corticosteroid therapy (within 3 to 6 months) and decrease after stopping therapy. The risk remained independent of underlying disease, age and gender. We conclude that oral corticosteroid treatment using more than 5 mg (of prednisolone or equivalent) daily leads to a reduction in bone mineral density and a rapid increase in the risk of fracture during the treatment period. Early use of preventive measures against corticosteroid-induced osteoporosis is recommended.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 14 January 2001 / Accepted: 25 March 2002
Rights and permissions
About this article
Cite this article
Staa, T., Staa, T., Staa, T. et al. The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis . Osteoporos Int 13, 777–787 (2002). https://doi.org/10.1007/s001980200108
Issue Date:
DOI: https://doi.org/10.1007/s001980200108